52

Biocon Group Ppt

Embed Size (px)

Citation preview

Page 1: Biocon Group Ppt
Page 2: Biocon Group Ppt
Page 3: Biocon Group Ppt
Page 4: Biocon Group Ppt
Page 5: Biocon Group Ppt
Page 6: Biocon Group Ppt
Page 7: Biocon Group Ppt
Page 8: Biocon Group Ppt
Page 9: Biocon Group Ppt
Page 10: Biocon Group Ppt

SCIENCE AND TECHNOLOGY

BY

DHIVYA JAYARAMAN

Page 11: Biocon Group Ppt
Page 12: Biocon Group Ppt
Page 13: Biocon Group Ppt
Page 14: Biocon Group Ppt
Page 15: Biocon Group Ppt
Page 16: Biocon Group Ppt
Page 17: Biocon Group Ppt
Page 18: Biocon Group Ppt
Page 19: Biocon Group Ppt
Page 20: Biocon Group Ppt
Page 21: Biocon Group Ppt
Page 22: Biocon Group Ppt
Page 23: Biocon Group Ppt
Page 24: Biocon Group Ppt
Page 25: Biocon Group Ppt
Page 26: Biocon Group Ppt
Page 27: Biocon Group Ppt
Page 28: Biocon Group Ppt
Page 29: Biocon Group Ppt
Page 30: Biocon Group Ppt

FINANCE

Page 31: Biocon Group Ppt
Page 32: Biocon Group Ppt
Page 33: Biocon Group Ppt

+25%$.1+10%$.320. Biocon (India)

NA($.1)+25%$.319. Nektar Therapeutics (U.S.)

100%($.1)+55%$.318. Crucell (Netherlands)

>999%$.1+51%$.317. Cubist Pharmaceuticals (U.S.)

NA(>$.1)+84%$.316. Abraxis Bioscience (U.S.)

>999%$.1+41%$.315. OSI Pharmaceuticals (U.S.)

NA>$.1+9%$.514. Millenium Pharmaceuticals (U.S.)

(>999%)>$.1(13%)$.613. ImClone Systems (U.S.)

(65%)($.4)+36%$.812. Elan (Ireland)

+3%($.2)+53%$.811. Amylin Pharmaceuticals (U.S.)

(49%)$.1+39%$1.110.Actelion (Switzerland)

+128%$.2+56%$1.49. Celgene (U.S.)

(>999%)($.2)+1%$1.88. Cephalon (U.S.)

+359%$.5+14%$2.87. CSL ( Australia)

+193%$.6+18%$3.26. Biogen Idec (U.S.)

>999%$.5+20%$3.85. Genzyme (U.S.)

>999%$1.6+40%$4.24. Gilead Sciences (U.S.)

(56%)$.2+42%$5.03. UCB (Belgium)

+31%$2.8+26%$11.72. Genentech (U.S.)

+7%$3.2+4%$14.81. Amgen (U.S.)

% Growth2007 Income

(billions)

% Growth2007 Revenue

(billions)

Company/Country

Page 34: Biocon Group Ppt

93.840.3354028Net Profit

48.2----Exceptional Item, Net

45.440.3354028Profit From Operations

1317311823Income Tax

4843.841.343.632.7Profit Before Tax

172156118.6104.676.6Total

1913.55.84.43.2Depreciation

21.80.40.40.4Interest and Finance Charges

151140.6112.498.473Manufacturing & Other Expenses

Expenditure

220200160147110Total Revenues

7.20.8130.2Other Income

212.6198.8159143.3109.8Total

44.432.82013.37.8Contract Research and Technical Licensing Fees

9.219171814Enzymes

15914712211288Bio Pharmaceuticals

Sales

20082007200620052004 In Thousand USD ($ 1000)

Page 35: Biocon Group Ppt
Page 36: Biocon Group Ppt
Page 37: Biocon Group Ppt
Page 38: Biocon Group Ppt

MARKETING BY XIAOYU LIANG

Page 39: Biocon Group Ppt
Page 40: Biocon Group Ppt
Page 41: Biocon Group Ppt
Page 42: Biocon Group Ppt

Until 2007 Global about 140millions

Page 43: Biocon Group Ppt
Page 44: Biocon Group Ppt
Page 45: Biocon Group Ppt
Page 46: Biocon Group Ppt
Page 47: Biocon Group Ppt
Page 48: Biocon Group Ppt
Page 49: Biocon Group Ppt

Strength Weakness

Page 50: Biocon Group Ppt
Page 51: Biocon Group Ppt

Opportunity Threat

Page 52: Biocon Group Ppt